Reutlingen, Germany

Roman Sellin

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Robert Bosch. Active years: 2012.



Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Roman Sellin: Innovator in Workpiece Composites

Introduction

Roman Sellin is a notable inventor based in Reutlingen, Germany. He has made significant contributions to the field of workpiece composites, particularly with his innovative patent that addresses the challenges of gel spreading in composite materials. His work reflects a deep understanding of material science and engineering.

Latest Patents

Roman Sellin holds a patent for a workpiece composite that features a preform and a gel. This invention includes a recess in the preform that is enclosed by at least one edge, which serves as a creep barrier to prevent the gel from spreading. The edge of the recess defines a termination point of at least one surface that is coated with an oleophobic material, enhancing the functionality of the composite.

Career Highlights

Throughout his career, Roman Sellin has worked with prominent organizations, including Robert Bosch and Technische Universität Berlin. His experience in these institutions has allowed him to refine his skills and contribute to various innovative projects in the field of engineering and materials science.

Collaborations

Roman has collaborated with esteemed colleagues such as Lutz Mueller and Hubert Benzel. These partnerships have fostered a creative environment that has led to advancements in their respective fields.

Conclusion

Roman Sellin's contributions to the field of workpiece composites exemplify his innovative spirit and dedication to engineering. His patent and collaborations highlight the importance of teamwork and creativity in driving technological advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…